Dongwha Pharm takes Whal Myung Su global with K.O.D.
Dongwha Pharm is taking its flagship digestive aid Whal Myung Su to the U.S. market, 129 years after the product was first developed in Korea. The pharmaceutical company said Thursday that it has launched a new Whal Myung Su 1897 product, branded as Korea Original Digestive (K.O.D.), for overseas consumers. It has also selected K-pop group CORTIS as its new global brand ambassador and plans to…
Dongwha Pharm, a pharmaceutical company, is introducing its popular digestive aid, Whal Myung Su, to the global market 129 years after its initial development in Korea. The company launched a new product called Korea Original Digestive (K.O.D.) on Thursday, specifically tailored for overseas consumers. To promote K.O.D. internationally, Dongwha Pharm has chosen the K-pop group CORTIS as its global brand ambassador. The company plans to execute a global marketing campaign centered around the group.
K.O.D. will be available at pharmacies and duty-free shops in Korea in the current month. Following that, the product will be distributed in supermarkets, pharmacies, and Olive Young stores across the United States starting in September. Additionally, Dongwha Pharm will maintain a dedicated K.O.D. brand store on Amazon.
Utilizing Whal Myung Su's 129-year legacy, which dates back to 1897, K.O.D. is designed as a food product with its taste and ingredients adjusted to suit the preferences of consumers in other countries. The company aims to establish K.O.D. as a part of a novel after-meal ritual for individuals who enjoy Korean cuisine. Dongwha Pharm's strategy centers around the concept of a "new cultural code for enjoying K-food."
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Dongwha Pharm takes Whal Myung Su global with K.O.D. koreatimes.co.kr
